oxidopamine has been researched along with Cranial Nerve II Injuries in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayarri, MJ | 1 |
| Rol de Lama, MA | 1 |
| Madrid, JA | 1 |
| Sánchez-Vázquez, FJ | 1 |
1 other study available for oxidopamine and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Both pineal and lateral eyes are needed to sustain daily circulating melatonin rhythms in sea bass.
Topics: Adrenergic Agents; Animals; Bass; Circadian Rhythm; Eye Enucleation; Melatonin; Ocular Physiological | 2003 |